Q3 2024 |
203 |
$1.89B |
+$60.3M |
-$40.3M |
+$20.1M |
NVDA, AAPL, MSFT, CARR, MA
|
13F-HR |
11/14/2024, 04:11 PM |
Q2 2024 |
198 |
$1.76B |
+$240M |
-$118M |
+$123M |
NVDA, AAPL, MSFT, MA, CARR
|
13F-HR |
8/13/2024, 01:43 PM |
Q1 2024 |
199 |
$1.74B |
+$67.7M |
-$51.9M |
+$15.9M |
NVDA, AAPL, MSFT, MA, NVO
|
13F-HR |
5/7/2024, 04:23 PM |
Q4 2023 |
195 |
$1.58B |
+$64.9M |
-$81.1M |
-$16.2M |
AAPL, NVDA, MSFT, MA, ROK
|
13F-HR |
2/7/2024, 04:37 PM |
Q3 2023 |
195 |
$1.46B |
+$60.9M |
-$48.3M |
+$12.6M |
AAPL, NVDA, MSFT, MA, ROK
|
13F-HR |
11/9/2023, 11:31 AM |
Q2 2023 |
206 |
$1.53B |
+$32.1M |
-$55.1M |
-$22.9M |
AAPL, NVDA, ROK, MSFT, MA
|
13F-HR |
8/9/2023, 10:59 AM |
Q1 2023 |
203 |
$1.45B |
+$23.2M |
-$59.8M |
-$36.6M |
AAPL, ROK, ADI, NVDA, MA
|
13F-HR |
5/3/2023, 11:45 AM |
Q4 2022 |
210 |
$1.36B |
+$24.4M |
-$56.4M |
-$32M |
AAPL, DHR, MA, ROK, ADI
|
13F-HR |
2/10/2023, 03:22 PM |
Q3 2022 |
207 |
$1.29B |
+$102M |
-$24.8M |
+$77.6M |
AAPL, DHR, MA, MSFT, ROK
|
13F-HR |
11/8/2022, 02:14 PM |
Q2 2022 |
218 |
$1.33B |
+$51.2M |
-$32.9M |
+$18.3M |
AAPL, DHR, MA, MSFT, ADI
|
13F-HR |
8/5/2022, 02:07 PM |
Q1 2022 |
230 |
$1.64B |
+$55.7M |
-$43.1M |
+$12.7M |
AAPL, DHR, NVDA, MSFT, MA
|
13F-HR |
5/11/2022, 04:21 PM |
Q4 2021 |
239 |
$1.76B |
+$30.1M |
-$33.7M |
-$3.54M |
AAPL, DHR, NVDA, ROK, MSFT
|
13F-HR |
2/11/2022, 03:34 PM |
Q3 2021 |
222 |
$1.63B |
+$72.3M |
-$25M |
+$47.3M |
AAPL, DHR, PYPL, ROK, MA
|
13F-HR |
11/15/2021, 05:27 PM |
Q2 2021 |
232 |
$1.63B |
+$42.3M |
-$34.4M |
+$7.89M |
AAPL, PYPL, DHR, MA, ROK
|
13F-HR |
8/12/2021, 02:23 PM |
Q1 2021 |
229 |
$1.5B |
+$79.4M |
-$57.3M |
+$22.1M |
AAPL, PYPL, MA, DHR, DIS
|
13F-HR |
5/7/2021, 12:16 PM |
Q4 2020 |
222 |
$1.46B |
+$43.8M |
-$47.1M |
-$3.36M |
AAPL, PYPL, MA, DHR, DIS
|
13F-HR |
2/10/2021, 04:41 PM |
Q3 2020 |
224 |
$1.3B |
+$129M |
-$27.9M |
+$101M |
AAPL, MA, DHR, PYPL, NKE
|
13F-HR |
10/28/2020, 01:28 PM |
Q2 2020 |
209 |
$1.14B |
+$83.8M |
-$27.3M |
+$56.5M |
AAPL, MA, PYPL, DHR, ROK
|
13F-HR |
8/14/2020, 03:06 PM |
Q1 2020 |
193 |
$878M |
+$39.7M |
-$57.5M |
-$17.8M |
AAPL, MA, DHR, TDOC, ABT
|
13F-HR |
5/13/2020, 01:26 PM |
Q4 2019 |
228 |
$1.04B |
+$44.6M |
-$22.5M |
+$22.1M |
AAPL, MA, DIS, DHR, ROK
|
13F-HR |
2/14/2020, 02:16 PM |
Q3 2019 |
224 |
$937M |
+$27.1M |
-$20.2M |
+$6.91M |
MA, AAPL, DHR, DIS, SYK
|
13F-HR |
11/8/2019, 03:56 PM |
Q2 2019 |
213 |
$932M |
+$19.5M |
-$35.8M |
-$16.3M |
MA, AAPL, DIS, DHR, PYPL
|
13F-HR |
8/6/2019, 04:21 PM |
Q1 2019 |
210 |
$904M |
+$46.5M |
-$18.8M |
+$27.7M |
MA, AAPL, DHR, PYPL, NVS
|
13F-HR |
5/10/2019, 02:26 PM |
Q4 2018 |
206 |
$754M |
+$34.3M |
-$24.3M |
+$10M |
MA, AAPL, JNJ, DIS, NVS
|
13F-HR |
2/14/2019, 04:21 PM |
Q3 2018 |
201 |
$851M |
+$20M |
-$31.2M |
-$11.2M |
AAPL, MA, JNJ, ILMN, DIS
|
Restatement |
11/26/2018, 11:37 AM |
Q2 2018 |
203 |
$784M |
+$38.6M |
-$66.5M |
-$27.9M |
MA, AAPL, JNJ, DIS, GOOGL
|
13F-HR |
8/9/2018, 03:05 PM |
Q1 2018 |
197 |
$791M |
+$59.8M |
-$25M |
+$34.7M |
MA, AAPL, JNJ, XYL, NVS
|
Restatement |
7/26/2018, 03:37 PM |
Q4 2017 |
202 |
$763M |
+$15.1M |
-$63.5M |
-$48.4M |
AAPL, PG, MA, JNJ, ROK
|
13F-HR |
2/6/2018, 05:18 PM |
Q3 2017 |
212 |
$767M |
+$27.6M |
-$40.4M |
-$12.8M |
PG, AAPL, MA, ROK, JNJ
|
13F-HR |
11/9/2017, 05:01 PM |
Q2 2017 |
222 |
$747M |
+$27.3M |
-$38.5M |
-$11.2M |
PG, AAPL, JNJ, CVS, ROK
|
13F-HR |
8/14/2017, 04:23 PM |
Q1 2017 |
223 |
$728M |
+$40.1M |
-$58.7M |
-$18.6M |
PG, AAPL, JNJ, CVS, ROK
|
13F-HR |
4/27/2017, 01:02 PM |
Q4 2016 |
225 |
$704M |
+$37M |
-$19M |
+$17.9M |
PG, CVS, AAPL, JNJ, ROK
|
13F-HR |
2/14/2017, 11:04 AM |
Q3 2016 |
211 |
$686M |
+$45M |
-$67.2M |
-$22.2M |
PG, CVS, AAPL, JNJ, NVS
|
13F-HR |
11/7/2016, 03:11 PM |
Q2 2016 |
218 |
$689M |
+$57M |
-$42.8M |
+$14.2M |
CVS, PG, JNJ, NVS, ROK
|
13F-HR |
8/3/2016, 05:40 PM |
Q1 2016 |
220 |
$676M |
+$105M |
-$45.4M |
+$60M |
CVS, PG, JNJ, MA, AAPL
|
13F-HR |
5/13/2016, 02:44 PM |
Q4 2015 |
201 |
$610M |
+$76.5M |
-$66.2M |
+$10.3M |
CVS, PG, MA, NVS, ADP
|
13F-HR |
2/16/2016, 02:55 PM |
Q3 2015 |
201 |
$574M |
+$48.7M |
-$23.6M |
+$25.1M |
CVS, PG, NVS, MA, ADP
|
13F-HR |
11/10/2015, 03:30 PM |
Q2 2015 |
204 |
$612M |
+$62.5M |
-$23.3M |
+$39.2M |
CVS, PG, NVS, JCI, MA
|
13F-HR |
8/12/2015, 03:31 PM |
Q1 2015 |
173 |
$582M |
+$59.4M |
-$50.7M |
+$8.68M |
CVS, PG, NVS, JCI, ADP
|
13F-HR |
5/8/2015, 05:30 PM |
Q4 2014 |
170 |
$570M |
+$32.8M |
-$21.9M |
+$10.9M |
CVS, PG, NVS, JCI, JNJ
|
13F-HR |
2/6/2015, 09:27 PM |
Q3 2014 |
163 |
$526M |
+$102M |
-$11.7M |
+$89.8M |
CVS, PG, NVS, JNJ, ADP
|
Restatement |
11/7/2014, 10:36 AM |
Q2 2014 |
163 |
$439M |
+$38.6M |
-$27M |
+$11.6M |
CVS, PG, JCI, JNJ, NVS
|
13F-HR |
8/11/2014, 01:11 PM |
Q1 2014 |
161 |
$422M |
+$29.1M |
-$12.4M |
+$16.6M |
PG, CVS, JCI, JNJ, NVS
|
13F-HR |
5/12/2014, 09:02 AM |
Q4 2013 |
157 |
$404M |
$0 |
$0 |
|
PG, CVS, JCI, ADP, EMR
|
13F-HR |
2/6/2014, 09:08 PM |